Trial Profile
A Phase II Study on Treatment of Refractory Fungal Infections With Posaconazole. The "TIP" Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- Acronyms TIP
- Sponsors Merck Sharp & Dohme
- 12 Mar 2015 New trial record